Exact Mass: 363.18343400000003
Exact Mass Matches: 363.18343400000003
Found 379 metabolites which its exact mass value is equals to given mass value 363.18343400000003
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Dioncophylline C
C23H25NO3 (363.18343400000003)
An isoquinoline alkaloid that is the biaryl resulting from substitution of the hydrogen at the 5-position of (1R,3R)-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-8-ol by a 5-hydroxy-4-methoxy-2-methylnaphthalen-1-yl group. It is a naphthylisoquinoline alkaloid isolated from the roots and stem barks of Triphyophyllum peltatum and exhibits antimalarial activity.
6-(1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopropyl)nicotinic acid
Methixene hydrochloride
C20H26ClNOS (363.1423536000001)
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent
Murrayanol
Murrayanol is found in herbs and spices. Murrayanol is an alkaloid from seeds of Murraya koenigii (curry leaf tree). Alkaloid from seeds of Murraya koenigii (curry leaf tree). Murrayanol is found in herbs and spices.
8-Methyldihydrochelerythrine
C22H21NO4 (363.14705060000006)
8-Methyldihydrochelerythrine is found in fruits. 8-Methyldihydrochelerythrine is an alkaloid from root bark of Zanthoxylum simulans (Szechuan pepper). Alkaloid from root bark of Zanthoxylum simulans (Szechuan pepper). 8-Methyldihydrochelerythrine is found in herbs and spices and fruits.
2-(1-(5-Fluoropentyl)-1H-indazole-3-ylcarbonylamino)-3-methylbutanoic acid methyl ester
Bucindolol
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Bucindolol is a β1-adrenergic receptor blocker, with intrinsic sympathomimetic activity, used in the research of heart failure[1].
(2S)-1-[(2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoyl]pyrrolidine-2-carboxylic acid
C16H21N5O5 (363.15426160000004)
Dioncophylline C
C23H25NO3 (363.18343400000003)
N-((Tetrahydro-5-oxo-2-furanyl)carbonyl)-L-histidyl-L-prolinamide
C16H21N5O5 (363.15426160000004)
6-[1-(3,5,5,8,8-Pentamethyl-6,7-dihydronaphthalen-2-yl)cyclopropyl]pyridine-2-carboxylic acid
Libenzapril
2-[[[4-(3-Benzylcyclobutyl)-1,3-thiazol-2-yl]diazenyl]methyl]phenol
C21H21N3OS (363.14052560000005)
Pglu-his-pro
C16H21N5O5 (363.15426160000004)
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones Thyrotropin-Releasing Hormone (TRH), Free Acid (TRH-OH) is a physiological metabolite of Thyrotropin-Releasing Hormone.
Thiencynonate
N-((2,2-Dimethyl-2,3-dihydro-benzofuran-7-yloxy)ethyl)-3-(cyclopent-1-enyl)benzylamine
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists
antofine
C23H25NO3 (363.18343400000003)
(-)-antofine is an organic heteropentacyclic compound that is (13aR)-9,11,12,13,13a,14-hexahydrodibenzo[f,h]pyrrolo[1,2-b]isoquinoline substituted at positions 2, 3 and 6 by methoxy groups. It is an alkaloid produced by relatives of the milkweed family and exhibits antiviral, anti-inflammatory, antiadipogenic and antitumorigenic activities. It has a role as an antineoplastic agent, a plant metabolite, a phytotoxin, an antimicrobial agent, an anti-inflammatory agent, an antiviral agent and an angiogenesis inhibitor. It is an organic heteropentacyclic compound, an aromatic ether, an alkaloid and an alkaloid antibiotic. (13aR)-2,3,6-trimethoxy-9,11,12,13,13a,14-hexahydrophenanthro[9,10-f]indolizine is a natural product found in Ficus septica, Vincetoxicum paniculatum, and other organisms with data available. An organic heteropentacyclic compound that is (13aR)-9,11,12,13,13a,14-hexahydrodibenzo[f,h]pyrrolo[1,2-b]isoquinoline substituted at positions 2, 3 and 6 by methoxy groups. It is an alkaloid produced by relatives of the milkweed family and exhibits antiviral, anti-inflammatory, antiadipogenic and antitumorigenic activities.
Opipramol
N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AA - Non-selective monoamine reuptake inhibitors D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-benzyl-1H-indole-3-carboxamide
1,3-dihydroxy-2,4-bis(3-methylbut-2-enyl)-9a,10-dihydro-4aH-acridin-9-one|1,3-dihydroxy-2,4-diprenylacridone|atalaphylline
C23H25NO3 (363.18343400000003)
2-[6-(1,3-Benzodioxole-5-yl)hexyl]-4-methoxyquinoline
C23H25NO3 (363.18343400000003)
(15E)-12beta-acetoxy-18-nor-senecionane-11,16-dione|Crotastriatin|crotastriatine|O-acetyl-nilgirine
3,7-dimethoxy-6-hydroxy-11,12,13,14,14a,15-hexahydro-9H-phenanthro[9,10-b]quinolizidine|Boehmeriasin B
C23H25NO3 (363.18343400000003)
(+)-miliusane V|8beta-acetylamino-9beta-hydroxy-1beta-(2,6-dimethylhepta-1,5-dienyl)-2-oxa-spiro[4.5]dec-7-ene-3,6-dione
C20H29NO5 (363.20456240000004)
(2E)-11-(4-aminophenyl)-5,9-dihydroxy-4,6,8-trimethyl-11-oxo-undec-2-enoic acid
C20H29NO5 (363.20456240000004)
(7E,9aS,11S,13S,13aS)-2,3,4,5,6,8,9,9a,10,11,12,13-dodecahydro-11-methyl-8-oxo-1H-indeno[1,7a-c]azonine-11,13-diyl diacetate|lycoposerramine-T
C20H29NO5 (363.20456240000004)
CAY10581
C22H21NO4 (363.14705060000006)
C21H21N3O3_8,8-Dimethyl-5a,6-dihydro-3H,5H,8H-spiro[indole-2,7-pyrrolo[1,2:4,5]pyrazino[1,2-a]azepine]-3,5,12(1H,2H)-trione
Cys Gly Gly Lys
C13H25N5O5S (363.15763200000004)
Cys Gly Lys Gly
C13H25N5O5S (363.15763200000004)
Cys Lys Gly Gly
C13H25N5O5S (363.15763200000004)
Gly Cys Gly Lys
C13H25N5O5S (363.15763200000004)
Gly Cys Lys Gly
C13H25N5O5S (363.15763200000004)
Gly Gly Cys Lys
C13H25N5O5S (363.15763200000004)
Gly Gly Lys Cys
C13H25N5O5S (363.15763200000004)
Gly Lys Cys Gly
C13H25N5O5S (363.15763200000004)
Gly Lys Gly Cys
C13H25N5O5S (363.15763200000004)
Gly Asn Ser Ser
Gly Ser Asn Ser
Gly Ser Ser Asn
Lys Cys Gly Gly
C13H25N5O5S (363.15763200000004)
Lys Gly Cys Gly
C13H25N5O5S (363.15763200000004)
Lys Gly Gly Cys
C13H25N5O5S (363.15763200000004)
Asn Gly Ser Ser
Asn Ser Gly Ser
Asn Ser Ser Gly
Ser Gly Asn Ser
Ser Gly Ser Asn
Ser Asn Gly Ser
Ser Asn Ser Gly
Ser Ser Gly Asn
Ser Ser Asn Gly
8-Methyldihydrochelerythrine
C22H21NO4 (363.14705060000006)
1-N-Boc-4-(2-Ncbzaminoethyl)piperazine
C19H29N3O4 (363.21579540000005)
Ethyl 5-amino-2-methyl-4-phenyl-1,4,6,7,8,9-hexahydrobenzo[b][1,8 ]naphthyridine-3-carboxylate
AMINO-(3,4-DIBENZYLOXY-PHENYL)-ACETIC ACID
C22H21NO4 (363.14705060000006)
2-(METHYLSULFANYL)[1,3]OXAZOLO[4,5-B]PYRIDINE
C22H21NO4 (363.14705060000006)
dimethyl-bis(prop-2-enyl)azanium,2-hydroxypropyl prop-2-enoate,prop-2-enoic acid,chloride
C17H30ClNO5 (363.18124000000006)
1-FMOC-4-CARBOXYMETHYLENE-PIPERIDINE
C22H21NO4 (363.14705060000006)
6-(4-(4-CYANOPHENYL)PHENOXY)HEXYL METHA&
C23H25NO3 (363.18343400000003)
3-HYDROXY-2,3-DIMETHYLBUTAN-2-YL HYDROGEN (3-((1,3-DIOXOISOINDOLIN-2-YL)METHYL)PHENYL)BORONATE
C21H22BNO4 (363.16418020000003)
benzyl 2-amino-5-methoxy-4-phenylmethoxybenzoate
C22H21NO4 (363.14705060000006)
(2-PHTALIMIDOMETHYLPHENYL)BORONIC ACID, PINACOL ESTER
C21H22BNO4 (363.16418020000003)
Urea, N-[2-[(3-cyano-8-methyl-2-quinolinyl)amino]ethyl]-N-(4-fluorophenyl)- (9CI)
C20H18FN5O (363.14953099999997)
Urea, N-[2-[(3-cyano-8-methyl-2-quinolinyl)amino]ethyl]-N-(2-fluorophenyl)- (9CI)
C20H18FN5O (363.14953099999997)
[2-(dimethylamino)-2-methylpropyl] 2-hydroxy-2,2-diphenylacetate,hydrochloride
C20H26ClNO3 (363.16011160000005)
(4-PHTHALIMIDOMETHYLPHENYL)BORONIC ACID, PINACOL ESTER
C21H22BNO4 (363.16418020000003)
[4-(Carbazol-9-yl)-1,1-biphenyl-4-yl]boronic acid
C24H18BNO2 (363.14305179999997)
1-CBZ-4-(2-N-BOC-AMINO-ETHYL)-PIPERAZINE
C19H29N3O4 (363.21579540000005)
(6,9-Diphenyl-9H-carbazol-3-yl)boronic acid
C24H18BNO2 (363.14305179999997)
1-Benzyl-4-[(5,6-dimethoxy-1H-inden-2-yl)methyl]piperidine
Efaproxiral sodium
C20H22NNaO4 (363.14464520000007)
C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent
3-{5-[(2R)-2-Aminopropyl]-7-cyano-2,3-dihydro-1H-indol-1-yl}propy l benzoate
erythro-N-[(Phenylmethoxy)carbonyl]-3-allyl-L-aspartic acid 1-tert-butyl ester
n-methoxy-n-methyl(triphenyl-phosphoranylidene)acetamide
Tris(methylethylketoxime)phenylsilane
C18H29N3O3Si (363.19780840000004)
1-[2-(4-(Trifluoromethyl)phenyl)ethyl]-6,7-dimethoxy-3,4-dihydroisoquinoline
C20H20F3NO2 (363.14460560000003)
((1R,2R)-2-AMINO-CYCLOHEXYL)-METHANOL
C20H27F2N3O (363.21220760000006)
Libenzapril
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Ozenoxacin
D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D004791 - Enzyme Inhibitors
Thiphenamil hydrochloride
C20H26ClNOS (363.1423536000001)
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
antazoline
C17H22N3O4P (363.13478620000006)
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents
4-ethenoxybutyl N-(3-triethoxysilylpropyl)carbamate
1-Morpholino-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)propan-2-ol
7-Amino-6-phenoxy-3-[(tetrahydrofuran-2-yl)methyl]quinazolin-4(3H)-one
Isopropyl 4-{5-[bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoate
C19H29N3O4 (363.21579540000005)
tert-butyl 3-{[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}azetidine-1-carboxylate
9-(Biphenyl-4-yl)carbazole-2-boronic acid
C24H18BNO2 (363.14305179999997)
4-(tert-Butyldiphenylsilyloxy)cyclohexanecarbonitrile
5-(2-Aminopropyl)-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile
4-(2-[2-METHOXY-4-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-PHENOXY]-ETHYL)-MORPHOLINE
GLY-PRO 4-METHOXY-BETA-NAPHTHYLAMIDE HYDROCHLORIDE
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tosyl-1,2,3,6-tetrahydropyridine
C18H26BNO4S (363.1675506000001)
1-Benzyl-4-(5,6-dimethoxy-1H-2-indenylmethyl)piperidine
l-d-(a-Aminoadipoyl)-l-cysteinyl-d-valine
C14H25N3O6S (363.14639900000003)
N-((1-(5-Fluoropentyl)-1H-indazol-3-yl)carbonyl)valine methyl ester
Dioncophylline B
C23H25NO3 (363.18343400000003)
A natural product found in Triphyophyllum peltatum.
2-[4-(1-adamantyl)-N-methylsulfonylanilino]acetic acid
C19H25NO4S (363.15042100000005)
Protuboxepin B
An organic heterotricyclic compound that is 10,11-dihydro-6H-oxepino[2,3-d]pyrazino[1,2-a]pyrimidine-6,9(8H)-dione substituted by a benzyl group at position 8 and an isopropyl group at position 11. It has been isolated from Aspergillus species.
2-[(4-amino-5-cyclohexyl-1,2,4-triazol-3-yl)thio]-N-(3-fluoro-4-methylphenyl)acetamide
D-Galactitol, 2-(acetylmethylamino)-2-deoxy-3,4,6-tri-O-methyl-, 1,5-diacetate
19-(Cyclopropylamino)-4,6,7,15-Tetrahydro-5h-16,1-(Azenometheno)-10,14-(Metheno)pyrazolo[4,3-O][1,3,9]triazacyclohexadecin-8(9h)-One
(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime
C20H18FN5O (363.14953099999997)
(2S)-1-[(2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoyl]pyrrolidine-2-carboxylic acid
C16H21N5O5 (363.15426160000004)
3-[[(E)-4-Methoxy-4-oxo-2-butenoyl]amino]-L-Ala-L-Phe-OH
C17H21N3O6 (363.14302860000004)
(1R,2R,5S,8S,9S,10R,11R,12R,13S)-5,12,13-trihydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate
N-acetyl-alpha-D-muramoyl-L-alaninate
C14H23N2O9- (363.14034879999997)
The carbohydrate acid derivative anion formed by loss of a proton from the carboxy group of N-acetyl-alpha-D-muramoyl-L-alanine; principal microspecies at pH 7.3.
3-{[(2E)-4-methoxy-4-oxobut-2-enoyl]amino}alanyl-L-phenylalanine
C17H21N3O6 (363.14302860000004)
5-[6-(Cyclohexylamino)-9-purinyl]-2-(hydroxymethyl)-4-methoxy-3-oxolanol
6-(1,3-benzodioxol-5-yl)-N-(3-oxanylmethyl)-4-quinazolinamine
2-[4-(2-methylpropyl)phenyl]propanoic acid [2-(1H-indol-3-yl)-2-oxoethyl] ester
C23H25NO3 (363.18343400000003)
(9S,11R)-12,12-dimethylspiro[1,7-diazatricyclo[7.5.0.03,7]tetradeca-3,13-diene-11,2-1H-indole]-2,3,8-trione
N-ethyl-N-(2-ethylphenyl)-3-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]propanamide
phe-FMDP
C17H21N3O6 (363.14302860000004)
A dipeptide composed of 3-{[(2E)-4-methoxy-4-oxobut-2-enoyl]amino}alanine and L-phenylalanine joined by peptide linkages.
2,4,5-trimethoxy-N-(2-phenylphenyl)benzamide
C22H21NO4 (363.14705060000006)
N-[1-(2,3-dimethylphenyl)-4,5,6,7-tetrahydroindazol-4-yl]-2,5-dimethyl-3-pyrazolecarboxamide
2-[[2-[1-(2-methoxyethyl)-2,5-dimethyl-3-pyrrolyl]-2-oxoethyl]thio]-6-propyl-1H-pyrimidin-4-one
N-[1-(3,4-dimethylphenyl)-4,5,6,7-tetrahydroindazol-4-yl]-2,5-dimethyl-3-pyrazolecarboxamide
1-(4-Fluorophenyl)-1-cyclopentanecarboxylic acid [2-(2,6-dimethyl-4-morpholinyl)-2-oxoethyl] ester
C20H26FNO4 (363.18457680000006)
6-fluoro-2-phenyl-N-(3-(piperidin-1-yl)propyl)quinolin-4-amine
C23H26FN3 (363.21106480000003)
5-[(3-Phenylmethoxy-1-piperidinyl)methyl]-3-(phenylmethyl)-1,2,4-oxadiazole
1-(1,3-benzoxazol-2-yl)-N-[(4-ethylphenyl)methyl]-3-piperidinecarboxamide
(5Z)-4-methoxy-3-methyl-5-[(1R,9R,10R,11R,12S)-12-methyl-5-oxido-14,15-dioxa-5-azoniatetracyclo[7.5.1.01,11.05,10]pentadecan-13-ylidene]furan-2-one
1-(4,6-dimethoxy-1,3,5-triazin-2-yl)-N-(thiophen-2-ylmethyl)-4-piperidinecarboxamide
C16H21N5O3S (363.1365036000001)
3-[[4-[(4-chlorophenyl)methyl]-4-(hydroxymethyl)-1-piperidinyl]-oxomethyl]-4,5-dihydro-1H-pyridazin-6-one
N-[(E)-(5-Morpholin-4-ylthiophen-2-yl)methylideneamino]-N-phenylaniline
C21H21N3OS (363.14052560000005)
3-methyl-2-[[2-(methylamino)-1-oxopropyl]amino]-N-[1-oxo-1-(phenylhydrazo)propan-2-yl]butanamide
N-[[(2S)-3beta-(Ethoxycarbonyl)aziridine-2alpha-yl]carbonyl]-Gly-Gly-OBzl
C17H21N3O6 (363.14302860000004)
6-(1,3-benzodioxol-5-yl)-N-(2-oxanylmethyl)-4-quinazolinamine
1-Tetradecanoyl-sn-glycero-2,3-cyclic phosphate
C17H32O6P- (363.19364020000006)
2-[(3R,4S)-3-[[5-(methoxymethyl)-1,2-oxazol-3-yl]methyl]piperidin-4-yl]-N-(thiophen-2-ylmethyl)acetamide
hydron;1-methyl-3-(9H-thioxanthen-9-ylmethyl)piperidine;chloride;hydrate
C20H26ClNOS (363.1423536000001)
N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3-oxanyl]-2-pyridinecarboxamide
2-[(3S,6aR,8R,10aR)-3-hydroxy-1-(pyridin-4-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
C19H29N3O4 (363.21579540000005)
3-(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)-N-(3,4-dihydro-2H-pyrrol-5-yl)benzamide
N-[(2R,3S,6S)-2-(hydroxymethyl)-6-(2-morpholin-4-yl-2-oxoethyl)oxan-3-yl]pyridine-2-carboxamide
N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3-oxanyl]-2-pyridinecarboxamide
2-[(3S,6aS,8R,10aS)-3-hydroxy-1-(pyridin-4-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
C19H29N3O4 (363.21579540000005)
2-[(3R,6aR,8R,10aR)-3-hydroxy-1-(pyridin-4-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
C19H29N3O4 (363.21579540000005)
2-[(3R,6aS,8S,10aS)-3-hydroxy-1-(pyridin-4-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
C19H29N3O4 (363.21579540000005)
2-[(3S,6aS,8S,10aS)-3-hydroxy-1-(pyridin-4-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
C19H29N3O4 (363.21579540000005)
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C19H29N3O4 (363.21579540000005)
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C19H29N3O4 (363.21579540000005)
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C19H29N3O4 (363.21579540000005)
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C19H29N3O4 (363.21579540000005)
N-[(5R,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C19H29N3O4 (363.21579540000005)
N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3-oxanyl]-2-pyridinecarboxamide
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-(pyridin-4-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
C19H29N3O4 (363.21579540000005)
2-[(3R,6aS,8R,10aS)-3-hydroxy-1-(pyridin-4-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
C19H29N3O4 (363.21579540000005)
4-oxanyl-[(1R,5S)-7-(4-pyridin-4-ylphenyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl]methanone
[(1-amino-2-naphthalen-1-ylethylidene)amino] N-(2-ethoxyphenyl)carbamate
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C19H29N3O4 (363.21579540000005)
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C19H29N3O4 (363.21579540000005)
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C19H29N3O4 (363.21579540000005)
N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C19H29N3O4 (363.21579540000005)
N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C19H29N3O4 (363.21579540000005)
N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C19H29N3O4 (363.21579540000005)
N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C19H29N3O4 (363.21579540000005)
N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3-oxanyl]-2-pyridinecarboxamide
N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3-oxanyl]-2-pyridinecarboxamide
N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3-oxanyl]-2-pyridinecarboxamide
N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3-oxanyl]-2-pyridinecarboxamide
2-[(3S,6aR,8S,10aR)-3-hydroxy-1-(pyridin-4-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
C19H29N3O4 (363.21579540000005)
(1S,5R)-N-(3-methoxyphenyl)-7-[4-[(E)-prop-1-enyl]phenyl]-3,6-diazabicyclo[3.1.1]heptane-6-carboxamide
(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]-3-phenylpropanoic acid
C19H29N3O4 (363.21579540000005)
(2R,3S,4S,5R,6S)-2-ethyl-6-{6-[(3-methylbut-2-en-1-yl)amino]-9H-purin-9-yl}oxane-3,4,5-triol
3-(4-Morpholinyl)-2-phenyl-1-[4-(trifluoromethyl)phenyl]-1-propanone
C20H20F3NO2 (363.14460560000003)
(2S)-2-[4-(1-Ethoxyethoxy)-1-oxobutyl]pyrrolidine-1-carboxylic acid benzyl ester
C20H29NO5 (363.20456240000004)
6-Methoxy-9-[2-(6-methylpyridin-3-yl)ethyl]-3-propyl-1,2,3,4-tetrahydro-gamma-carboline
[2-[Acetyl(methyl)amino]-5-acetyloxy-1-deuterio-3,4,6-trimethoxyhexyl] acetate
Methyl (2S)-2-[1-(5-fluoropentyl)-1H-indazole-3-carboxamido]-3-methylbutanoate
E1231
E1231 is an orally active activator of Sirtuin 1 (SIRT1) (EC50=0.83 μM), to modulate cholesterol and lipid metabolism. E1231 interactes with SIRT1 (KD=9.61 μM) and deacetylated liver X receptor-alpha (LXRα), and increases ATP-binding cassette transporter A1 (ABCA1) expression. E1231 also reduces atherosclerotic plaque development in ApoE-/- mice model. E1231 can be used for research in cholesterol and lipid disorder-related diseases[1]. E1231 is an orally active activator of Sirtuin 1 (SIRT1) (EC50=0.83 μM), to modulate cholesterol and lipid metabolism. E1231 interactes with SIRT1 (KD=9.61 μM) and deacetylated liver X receptor-alpha (LXRα), and increases ATP-binding cassette transporter A1 (ABCA1) expression. E1231 also reduces atherosclerotic plaque development in ApoE-/- mice model. E1231 can be used for research in cholesterol and lipid disorder-related diseases[1].
ZINC13466751
ZINC13466751 is a potent inhibitor of HIF-1α/von Hippel-Lindau interaction with an IC50 of 2.0 μM[1].